Skip to main content
Top
Published in: European Radiology 11/2009

01-11-2009 | Vascular-Interventional

MR-lymphangiography at 3.0T—a feasibility study

Authors: Mike Notohamiprodjo, Ruediger G. H. Baumeister, Tobias F. Jakobs, Kerstin U. Bauner, Holger F. Boehm, Annie Horng, Maximilian F. Reiser, Christian Glaser, Karin A. Herrmann

Published in: European Radiology | Issue 11/2009

Login to get access

Abstract

The purpose of this study was to establish and evaluate contrast-enhanced MR-lymphangiography (MRL) at 3.0T for detection and visualization of abnormalities of the peripheral lymphatic system. Sixteen patients were examined with a highly resolved isotropic T1w-3D-GRE-(FLASH) sequence (TR 3.76 ms/TE 1.45 ms/FA 30°/voxel-size 0.8 × 0.8 × 0.8 mm3) at 3T after intracutaneous injection of gadolinium-diethylene-triamine-pentaacetic-acid. Two radiologists evaluated overall image quality, contrast between lymph vessels and background tissue, venous contamination, visualized levels, and fat-saturation-homogeneity on 3D maximum-intensity projections. Overall image quality was good to excellent, and all examinations were diagnostic except one, where contrast medium was injected subcutaneously instead of intracutaneously. Overall image quality was good to excellent in 12/16 cases, depiction of lymph vessels was good to excellent in 15/16 cases. Venous contamination was always present, but diagnostically problematical in only one case. Instant lymphatic drainage was observed in unaffected extremities, reaching the pelvic level after approximately 10 min. Lymphatic drainage was considerably delayed in lymphedematous extremities. Ectatic lymph vessels, entrapment, and diffuse drainage of contrast medium correlated with impaired lymphatic drainage. In conclusion, MRL at 3.0T provides very high spatial resolution and anatomical detail of normal and abnormal peripheral lymph vessels. MRL may thus become a valuable tool for microsurgical treatment planning and monitoring.
Literature
3.
go back to reference Pecking AP, Alberini JL, Wartski M, Edeline V, Cluzan RV (2008) Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging. Lymphology 41:1–10PubMed Pecking AP, Alberini JL, Wartski M, Edeline V, Cluzan RV (2008) Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging. Lymphology 41:1–10PubMed
4.
go back to reference Weiss M, Baumeister RG, Tatsch K, Hahn K (1996) Lymphoscintigraphy for non-invasive long term follow-up of functional outcome in patients with autologous lymph vessel transplantation. Nuklearmedizin 35:236–242PubMed Weiss M, Baumeister RG, Tatsch K, Hahn K (1996) Lymphoscintigraphy for non-invasive long term follow-up of functional outcome in patients with autologous lymph vessel transplantation. Nuklearmedizin 35:236–242PubMed
5.
go back to reference Weissleder H, Weissleder R (1988) Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 167:729–735PubMed Weissleder H, Weissleder R (1988) Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 167:729–735PubMed
6.
go back to reference Lohrmann C, Foeldi E, Speck O, Langer M (2006) High-resolution MR lymphangiography in patients with primary and secondary lymphedema. AJR Am J Roentgenol 187:556–561CrossRefPubMed Lohrmann C, Foeldi E, Speck O, Langer M (2006) High-resolution MR lymphangiography in patients with primary and secondary lymphedema. AJR Am J Roentgenol 187:556–561CrossRefPubMed
7.
go back to reference Lohrmann C, Foeldi E, Bartholoma JP, Langer M (2007) Magnetic resonance imaging of lymphatic vessels without image subtraction: a practicable imaging method for routine clinical practice? J Comput Assist Tomogr 31:303–308CrossRefPubMed Lohrmann C, Foeldi E, Bartholoma JP, Langer M (2007) Magnetic resonance imaging of lymphatic vessels without image subtraction: a practicable imaging method for routine clinical practice? J Comput Assist Tomogr 31:303–308CrossRefPubMed
8.
go back to reference Lohrmann C, Felmerer G, Foeldi E, Bartholoma JP, Langer M (2008) MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstructions of lymphatic vessels. Microvasc Res 76:42–45CrossRefPubMed Lohrmann C, Felmerer G, Foeldi E, Bartholoma JP, Langer M (2008) MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstructions of lymphatic vessels. Microvasc Res 76:42–45CrossRefPubMed
9.
go back to reference Michaely HJ, Kramer H, Attenberger U, Sourbron SP, Weckbach S, Reiser MF, Schoenberg SO (2007) Renal magnetic resonance angiography at 3.0 T: technical feasibility and clinical perspectives. Top Magn Reson Imaging 18:117–125CrossRefPubMed Michaely HJ, Kramer H, Attenberger U, Sourbron SP, Weckbach S, Reiser MF, Schoenberg SO (2007) Renal magnetic resonance angiography at 3.0 T: technical feasibility and clinical perspectives. Top Magn Reson Imaging 18:117–125CrossRefPubMed
10.
go back to reference Schoenberg SO, Rieger J, Weber CH, Michaely HJ, Waggershauser T, Ittrich C, Dietrich O, Reiser MF (2005) High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Radiology 235:687–698CrossRefPubMed Schoenberg SO, Rieger J, Weber CH, Michaely HJ, Waggershauser T, Ittrich C, Dietrich O, Reiser MF (2005) High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Radiology 235:687–698CrossRefPubMed
11.
12.
go back to reference Kramer H, Michaely HJ, Matschl V, Schmitt P, Reiser MF, Schoenberg SO (2007) High-resolution magnetic resonance angiography of the lower extremities with a dedicated 36-element matrix coil at 3 Tesla. Invest Radiol 42:477–483CrossRefPubMed Kramer H, Michaely HJ, Matschl V, Schmitt P, Reiser MF, Schoenberg SO (2007) High-resolution magnetic resonance angiography of the lower extremities with a dedicated 36-element matrix coil at 3 Tesla. Invest Radiol 42:477–483CrossRefPubMed
13.
go back to reference Kramer H, Michaely HJ, Reiser MF, Schoenberg SO (2007) Peripheral magnetic resonance angiography at 3.0 T. Top Magn Reson Imaging 18:135–138CrossRefPubMed Kramer H, Michaely HJ, Reiser MF, Schoenberg SO (2007) Peripheral magnetic resonance angiography at 3.0 T. Top Magn Reson Imaging 18:135–138CrossRefPubMed
14.
go back to reference Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang J, Kiefer B, Haase A (2002) Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47:1202–1210CrossRef Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang J, Kiefer B, Haase A (2002) Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47:1202–1210CrossRef
15.
go back to reference Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO (2007) Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging 26:375–385CrossRefPubMed Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO (2007) Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging 26:375–385CrossRefPubMed
16.
go back to reference Weiss M, Baumeister RG, Hahn K (2003) Dynamic lymph flow imaging in patients with oedema of the lower limb for evaluation of the functional outcome after autologous lymph vessel transplantation: an 8-year follow-up study. Eur J Nucl Med Mol Imaging 30:202–206PubMed Weiss M, Baumeister RG, Hahn K (2003) Dynamic lymph flow imaging in patients with oedema of the lower limb for evaluation of the functional outcome after autologous lymph vessel transplantation: an 8-year follow-up study. Eur J Nucl Med Mol Imaging 30:202–206PubMed
17.
go back to reference Clement O, Luciani A (2004) Imaging the lymphatic system: possibilities and clinical applications. Eur Radiol 14:1498–1507CrossRefPubMed Clement O, Luciani A (2004) Imaging the lymphatic system: possibilities and clinical applications. Eur Radiol 14:1498–1507CrossRefPubMed
18.
go back to reference Merkle EM, Dale BM, Paulson EK (2006) Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am 14:17–26CrossRefPubMed Merkle EM, Dale BM, Paulson EK (2006) Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am 14:17–26CrossRefPubMed
19.
go back to reference Maas M, Dijkstra PF, Akkerman EM (1999) Uniform fat suppression in hands and feet through the use of two-point Dixon chemical shift MR imaging. Radiology 210:189–193PubMed Maas M, Dijkstra PF, Akkerman EM (1999) Uniform fat suppression in hands and feet through the use of two-point Dixon chemical shift MR imaging. Radiology 210:189–193PubMed
20.
go back to reference Michaely HJ, Attenberger U, Kramer H, Reiser MF, Schoenberg SO (2008) Gadofosveset-enhanced steady state MRA of the peripheral vessels with Dixon fat-saturation. Proc Intl Soc Mag Reson Med 16:112 Michaely HJ, Attenberger U, Kramer H, Reiser MF, Schoenberg SO (2008) Gadofosveset-enhanced steady state MRA of the peripheral vessels with Dixon fat-saturation. Proc Intl Soc Mag Reson Med 16:112
21.
go back to reference Cohan RH, Leder RA, Herzberg AJ, Hedlund LW, Wheeler CT, Beam CA, Nadel SN, Dunnick NR (1991) Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat. Invest Radiol 26:224–226CrossRefPubMed Cohan RH, Leder RA, Herzberg AJ, Hedlund LW, Wheeler CT, Beam CA, Nadel SN, Dunnick NR (1991) Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat. Invest Radiol 26:224–226CrossRefPubMed
22.
go back to reference Fink C, Bock M, Kiessling F, Delorme S (2002) Interstitial magnetic resonance lymphography with gadobutrol in rats: evaluation of contrast kinetics. Invest Radiol 37:655–662CrossRefPubMed Fink C, Bock M, Kiessling F, Delorme S (2002) Interstitial magnetic resonance lymphography with gadobutrol in rats: evaluation of contrast kinetics. Invest Radiol 37:655–662CrossRefPubMed
23.
go back to reference Runge VM, Dickey KM, Williams NM, Peng X (2002) Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media. Invest Radiol 37:393–398CrossRefPubMed Runge VM, Dickey KM, Williams NM, Peng X (2002) Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media. Invest Radiol 37:393–398CrossRefPubMed
24.
go back to reference Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H (1993) Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28(Suppl 1):S28–43PubMedCrossRef Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H (1993) Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28(Suppl 1):S28–43PubMedCrossRef
25.
go back to reference Kirchin MA, Runge VM (2003) Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging 14:426–435CrossRefPubMed Kirchin MA, Runge VM (2003) Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging 14:426–435CrossRefPubMed
26.
go back to reference Weiss M, Gildehaus FJ, Brinkbaumer K, Makowski M, Hahn K (2005) Lymph kinetics with technetium-99m labeled radiopharmaceuticals. Animal studies. Nuklearmedizin 44:156–165PubMed Weiss M, Gildehaus FJ, Brinkbaumer K, Makowski M, Hahn K (2005) Lymph kinetics with technetium-99m labeled radiopharmaceuticals. Animal studies. Nuklearmedizin 44:156–165PubMed
27.
go back to reference Weiss M, Baumeister RG, Hahn K (2003) Planning and monitoring of autologous lymph vessel transplantation by means of nuclear medicine lymphoscintigraphy. Handchir Mikrochir Plast Chir 35:210–215CrossRefPubMed Weiss M, Baumeister RG, Hahn K (2003) Planning and monitoring of autologous lymph vessel transplantation by means of nuclear medicine lymphoscintigraphy. Handchir Mikrochir Plast Chir 35:210–215CrossRefPubMed
28.
go back to reference Ruehm SG, Schroeder T, Debatin JF (2001) Interstitial MR lymphography with gadoterate meglumine: initial experience in humans. Radiology 220:816–821CrossRefPubMed Ruehm SG, Schroeder T, Debatin JF (2001) Interstitial MR lymphography with gadoterate meglumine: initial experience in humans. Radiology 220:816–821CrossRefPubMed
29.
go back to reference Vogl TJ, Pegios W, McMahon C, Balzer J, Waitzinger J, Pirovano G, Lissner J (1992) Gadobenate dimeglumine–a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR Am J Roentgenol 158:887–892PubMed Vogl TJ, Pegios W, McMahon C, Balzer J, Waitzinger J, Pirovano G, Lissner J (1992) Gadobenate dimeglumine–a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR Am J Roentgenol 158:887–892PubMed
30.
go back to reference Anonymous (2004) Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018. Drugs R D 5:339–342 Anonymous (2004) Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018. Drugs R D 5:339–342
Metadata
Title
MR-lymphangiography at 3.0T—a feasibility study
Authors
Mike Notohamiprodjo
Ruediger G. H. Baumeister
Tobias F. Jakobs
Kerstin U. Bauner
Holger F. Boehm
Annie Horng
Maximilian F. Reiser
Christian Glaser
Karin A. Herrmann
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
European Radiology / Issue 11/2009
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-009-1461-z

Other articles of this Issue 11/2009

European Radiology 11/2009 Go to the issue